Attorney Wire Briefing: May 22, 2026
Includes OpenAI’s win over Elon Musk, SEC public-company reporting changes, a Title IX workplace protections review, Takeda’s pay-for-delay verdict, and DOJ antitrust indictments.
Good morning — it’s Friday, May 22, 2026.
Here are six key legal developments we’re following.
Estimated read time: 4 minutes
Lead Story
OpenAI Defeats Musk Lawsuit Over Corporate Direction
What happened: OpenAI defeated Elon Musk’s $150 billion lawsuit after an advisory jury found his claims were barred by the statute of limitations. Musk alleged OpenAI abandoned its nonprofit mission by adopting a commercial structure and taking Microsoft investment. The federal judge accepted the verdict and dismissed the claims.
Why it matters: The ruling removes a major legal challenge to OpenAI’s corporate structure and commercial strategy. It also highlights how procedural defenses, not just substantive corporate governance arguments, can decide high-stakes business litigation.
Implication: For attorneys advising founders, boards, and investors, the case underscores the importance of timing, standing, and procedural posture in governance disputes. The decision also removes a significant obstacle as OpenAI pursues continued commercial expansion and a possible IPO.
Read more: Associated Press | Post Trial Order
The Docket
SEC Proposes Major Public Company Reporting Rollback
The SEC proposed rule changes to make it easier for companies to go public and remain public. The plan raises the “large accelerated filer” threshold from $700 million to $2 billion, expands offering flexibilities beyond WKSIs, and gives newly public companies a five-year on-ramp before stricter reporting requirements apply.
Why it matters: If adopted, the changes would reduce compliance burdens under federal securities laws and allow more companies to remain exempt from Section 404(b) Sarbanes-Oxley auditor attestation requirements for longer.
Read more: U.S. Securities and Exchange Commission
…..
Supreme Court to Review Scope of Title IX Workplace Protections
The Supreme Court agreed to consider whether school employees may bring sex-based discrimination claims under Title IX, the federal law barring sex-based discrimination in federally funded education programs, or are limited to Title VII remedies. The case stems from an 11th Circuit ruling holding that Title IX does not authorize standalone employment discrimination claims by school employees.
Why it matters: The case could clarify the relationship between Title IX and Title VII for federally funded schools, colleges, and universities. A decision limiting Title IX claims could narrow employee remedies by requiring compliance with Title VII’s administrative procedures and damages caps.
Read more: Reuters | Petition for Writ of Certiorari
…..
Justice Department Indicts Raúl Castro
The U.S. Department of Justice indicted former Cuban President Raúl Castro for murder and conspiracy in connection with the 1996 downing of two civilian aircraft that killed U.S. citizens. The indictment also charges five Cuban fighter pilots involved in the attack.
Why it matters: The prosecution tests the reach of U.S. extraterritorial criminal jurisdiction and command-responsibility theories involving foreign officials. Although sovereign immunity and extradition obstacles may limit enforcement, the case marks a significant attempt to apply U.S. criminal law to foreign military actions.
Read more: Reuters | Superseding Indictment
…..
Jury Awards $885 Million in Takeda Pay-for-Delay Verdict
A federal jury in Massachusetts found Takeda Pharmaceutical liable for using an anticompetitive “pay-for-delay” agreement to block generic competition for Amitiza, awarding about $885 million. Plaintiffs argued Takeda’s 2014 patent settlement with Par Pharmaceutical unlawfully delayed a cheaper generic version. Most of the award is subject to treble damages and Takeda’s total exposure could exceed $2.4 billion.
Why it matters: The verdict is the first plaintiffs’ jury win in pharmaceutical pay-for-delay litigation since the Supreme Court’s 2013 FTC v. Actavis decision, which held that patent settlements in which brand-name manufacturers compensate generic rivals to delay market entry may violate antitrust law. The ruling raises the stakes for pharmaceutical companies using Hatch-Waxman settlements and may strengthen plaintiffs’ leverage in future reverse-payment antitrust cases.
Read more: Reuters | Jury Verdict Form
…..
Justice Department Indicts Shipping Container Manufacturers in Price-Fixing Case
The Justice Department indicted four shipping container manufacturers and seven executives for violating Section 1 of the Sherman Act. Prosecutors allege the companies, which make about 95% of the world’s standard dry shipping containers, conspired between 2019 and 2021 to restrict output and fix prices, causing U.S. customers to pay more and wait longer for goods during the pandemic.
Why it matters: The case underscores the Antitrust Division’s focus on individual accountability and international cartel enforcement in global supply chains. Antitrust counsel should note the use of criminal charges, cross-border arrests, and extradition against foreign companies and executives accused of price-fixing affecting U.S. commerce.
Read more: Wall Street Journal | Superseding Indictment
Partner Signal
The Largest Firms Are Pulling Further Ahead on Pricing
Am Law 100 firms increased billing rates 9.8% in Q1 2026, compared with 5.3% growth at midsize firms. The widening gap matters because pricing power is increasingly tied to scale, client mix, technology investment, and the ability to absorb higher overhead without weakening margins.
What We’re Watching
SEC Rescinds Long-Standing Enforcement Settlement No-Deny Policy
The Securities and Exchange Commission rescinded its long-standing policy requiring settling defendants to agree not to publicly deny agency allegations. The change could give counsel more flexibility in negotiating resolutions and advising clients on post-settlement communications.
Brought to You by Attorney Credits
Now offering Live CLE Webinars. Serving over 130K attorneys with more than 3 million courses delivered.